Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose tolerance or diabetes.

Trial Profile

Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose tolerance or diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Somatropin/mecasermin (Primary)
  • Indications Diabetes mellitus; Glucose intolerance
  • Focus Therapeutic Use
  • Acronyms GH-IGF-I
  • Most Recent Events

    • 24 Mar 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 24 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top